The EDC is live today — see what ships now
All studies
NCT06423573From ClinicalTrials.govRecruiting

A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez

A Long-term Non-interventional Study to Assess the Incidence of Skin Malignancies in Patients With Dystrophic and Junctional Epidermolysis Bullosa Receiving Treatment With Filsuvez

  • Epidermolysis Bullosa, Dystrophic
  • Epidermolysis Bullosa, Junctional

At a glance

Phase
Phase not stated
Study type
Observational
Sponsor
Chiesi Farmaceutici S.p.A.
Enrolment target
170
Started
18 December 2024
Main results due
30 November 2031
Study sites
12
Registry updated
28 September 2026

Can you take part?

  • No age limit is stated.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

* Patients with a confirmed diagnosis of dystrophic EB or junctional EB

Exclusion Criteria:

* None

What this study is about

In the sponsor’s own words, from the registry.

In patients with epidermolysis bullosa (EB), collagen does not form properly, so their skin is very fragile and blisters easily. Such patients are also at greatly increased risk of developing skin cancers. Filsuvez is a topical gel used to promote healing of skin lesions in patients with certain types of EB. In this observational study, patients with either dystrophic EB (DEB) or junctional EB (JEB) will receive standard of care treatment, whether Filsuvez or something else, and will be followed for a minimum of 3 years. The main purpose is to see if the use of Filsuvez affects the likelihood of developing skin malignancies in these patient populations.

Study sites(12)

  • Lucile Packard Children's Hospital

    Palo Alto, California, United States

    Not yet recruiting

  • UCHealth / Children's Hospital Colorado

    Aurora, Colorado, United States

    Not yet recruiting

  • UF College of Medicine

    Gainesville, Florida, United States

    Not yet recruiting

  • Cincinnati Children's

    Cincinnati, Ohio, United States

    Not yet recruiting

  • Childrens Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

    Not yet recruiting

  • Medical University of South Carolina

    Charleston, South Carolina, United States

    Not yet recruiting

  • CHU de Toulouse, Hôpital Larrey

    Toulouse, France

    Recruiting

  • UMC Freiburg EB Centre

    Freiburg im Breisgau, Germany

    Recruiting

  • Hospital of Skin and Venereal Diseases of Thessaloniki

    Thessaloniki, Greece

    Recruiting

  • Hospital Clinic, Barcelona

    Barcelona, Spain

    Recruiting

  • Hospital San Juan de Dios (Barcelona)

    Barcelona, Spain

    Recruiting

  • Guy's and St Thomas' NHS Foundation Trust

    London, United Kingdom

    Recruiting

Showing 12 of 12 sites. 6 of the 12 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT06423573. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez | Trialion